CRISPR-TB Blood Test Gets FDA Breakthrough Device Designation
The test uses a molecular diagnostic platform to detect Mycobacterium tuberculosis DNA in blood samples.
The test uses a molecular diagnostic platform to detect Mycobacterium tuberculosis DNA in blood samples.
The test uses a molecular diagnostic platform to detect Mycobacterium tuberculosis DNA in blood samples.
Read MoreA single inhalation CT scan combined with a deep learning model can accurately diagnose and stage COPD.
Read MoreThe EasyOne Sky handheld spirometer from ndd Medical Technologies features a built-in coach to help simplify lung function testing.
Read MoreAlveo Technologies has entered an agreement with the CDC to develop a rapid molecular diagnostic test capable of detecting and differentiating avian influenza and seasonal influenza viruses at the point of need.
Read MoreResearchers developed a self-screening device, which they hope to commercialize, to help users detect diseases like COPD and asthma early using multi-sensory breathing information.
Read MoreThe World Health Organization has granted Emergency Use Listing to a rapid PCR-based mpox test, enhancing access to point-of-care diagnostics.
Read MoreDiffusion capacity of the lungs for carbon monoxide (DLCO) testing is used to assess the transfer of gases from the alveoli into the bloodstream. Abnormal DLCO results can help diagnose, distinguish, and manage cardiopulmonary diseases such as asthma.
Read MoreThe new software will leverage natural language processing capabilities to evaluate EHR data along with imaging AI to identify and triage patients suspected of lung disease.
Read MoreA new clearance from the FDA allows the MGC Diagnostics Ascent cardiorespiratory diagnostic software to be used for both pulmonary function testing (PFT) and cardiopulmonary exercise testing (CPET).
Read MoreStill the gold standard in measuring blood oxygen levels, arterial blood gas analysis continues to move out of the diagnostics lab and straight to the patient’s bedside.
Read MoreBeginning October 2024, Cosmed released its Omnia 2.4.2 software, enabling greater performance with new software functionalities and enhancements.
Read MoreThe test, for use without a prescription, marks the first flu/COVID-19 test to be authorized outside of emergency use authorities.
Read MoreA proof-of-concept study demonstrates the potential of a noninvasive breath-based device to quickly diagnose lower respiratory tract infections.
Read MoreThe wearable patch, equipped with deep learning technology, detects wheezing with greater accuracy than digital stethoscopes, offering potential improvements in asthma and COPD diagnosis.
Read MoreThe experimental blood test analyzes 32 proteins to predict an individual’s risk of developing severe lung diseases like COPD, offering potential for earlier intervention.
Read MoreThe US FDA has granted 510(k) clearance to a contactless, under-the-mattress device designed to aid in the diagnosis of obstructive sleep apnea.
Read MoreNonin’s partnership with EnsoData aims to bring accessible sleep testing and diagnosis to all audiences, including patients with limited access to care.
Read MoreA proof-of-concept study demonstrated that the handheld device captures lung sounds with accuracy comparable to a digital stethoscope.
Read MoreTrudell Medical is expanding into respiratory diagnostics with an agreement to acquire Vyaire Medical RDx, which includes pulmonary function testing devices.
Read MoreThe system diagnosed a variety of health conditions, including asthma and COVID-19, with 98% accuracy.
Read MoreNIH-supported research finds that routine laboratory tests are not effective in diagnosing long COVID, highlighting the need for novel biomarkers that distinguish the condition from other ailments.
Read MoreThe saliva test provides a more accurate and child-friendly alternative to blood tests for predicting the severity of respiratory infections, research finds.
Read MoreThe home sleep test, worn on the wrist and finger, was validated against polysomnography for sleep apnea and sleep staging.
Read MoreGEM Premier 7000 with iQM3, unveiled at the ADLM Annual Meeting, introduces hemolysis detection at point-of-care, detecting and flagging hemolysis in 45 seconds.
Read More